| 000 | 01871 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250515182522.0 | ||
| 264 | 0 | _c20090922 | |
| 008 | 200909s 0 0 eng d | ||
| 022 | _a1477-9226 | ||
| 024 | 7 |
_a10.1039/b819061e _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSpencer, John | |
| 245 | 0 | 0 |
_aSynthesis of a 1,4-benzodiazepine containing palladacycle with in vitro anticancer and cathepsin B activity. _h[electronic resource] |
| 260 |
_bDalton transactions (Cambridge, England : 2003) _cJun 2009 |
||
| 300 |
_a4299-303 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xchemical synthesis |
| 650 | 0 | 4 |
_aBenzodiazepines _xchemical synthesis |
| 650 | 0 | 4 |
_aCathepsin B _xantagonists & inhibitors |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 | _aChlorocebus aethiops |
| 650 | 0 | 4 | _aCrystallography, X-Ray |
| 650 | 0 | 4 | _aDrug Screening Assays, Antitumor |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInhibitory Concentration 50 |
| 650 | 0 | 4 |
_aLeukemia, Myelogenous, Chronic, BCR-ABL Positive _xdrug therapy |
| 650 | 0 | 4 |
_aLiver _xenzymology |
| 650 | 0 | 4 | _aMagnetic Resonance Spectroscopy |
| 650 | 0 | 4 | _aModels, Molecular |
| 650 | 0 | 4 | _aMolecular Structure |
| 650 | 0 | 4 |
_aPalladium _xchemistry |
| 650 | 0 | 4 | _aVero Cells |
| 700 | 1 | _aRathnam, Rajendra P | |
| 700 | 1 | _aMotukuri, Mahesh | |
| 700 | 1 | _aKotha, Arun K | |
| 700 | 1 | _aRichardson, Simon C W | |
| 700 | 1 | _aHazrati, Ali | |
| 700 | 1 | _aHartley, John A | |
| 700 | 1 | _aMale, Louise | |
| 700 | 1 | _aHursthouse, Michael B | |
| 773 | 0 |
_tDalton transactions (Cambridge, England : 2003) _gno. 22 _gp. 4299-303 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1039/b819061e _zAvailable from publisher's website |
| 999 |
_c19068870 _d19068870 |
||